price
RG
NASDAQ · RGNX
REGENXBIO Inc.
Healthcare · Biotechnology
$7.17
Down-$0.32 (-4.46%)
Updated Oct 23, 2026, 2:58 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 650.96M
- P/E ratio
- -3.74
- Dividend yield
- 0.00%
- 52-week range
- $5.46 – $15.88
- Volume
- 1.13M
- Avg. volume
- 586.76K
Price performance · RGNX
RGNX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 22, 2026
RGNX closed at $7.17 after 21 trading sessions, down 0.97% for the selected period.
- Last close
- $7.17
- Period change
- -0.97%
- Period low
- $6.88
- Period high
- $8.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | $7.11 | $7.305 | $6.98 | $7.17 | 1.13M |
| Oct 21, 2026 | $7.42 | $7.47 | $7.15 | $7.17 | 945.33K |
| Oct 20, 2026 | $7.15 | $7.58 | $7.06 | $7.40 | 1.32M |
| Oct 19, 2026 | $6.98 | $7.265 | $6.95 | $7.15 | 1.3M |
| Oct 16, 2026 | $7.14 | $7.18 | $6.875 | $6.925 | 1.21M |
| Oct 15, 2026 | $6.88 | $7.28 | $6.83 | $7.16 | 1.23M |
| Oct 14, 2026 | $7.12 | $7.24 | $6.80 | $6.88 | 1.57M |
| Oct 13, 2026 | $7.66 | $7.72 | $7.11 | $7.26 | 1.38M |
| Oct 12, 2026 | $8.12 | $8.29 | $7.74 | $7.77 | 2.03M |
| Oct 9, 2026 | $8.03 | $8.275 | $7.95 | $8.07 | 859.29K |
| Oct 8, 2026 | $7.50 | $8.31 | $7.44 | $8.09 | 2.26M |
| Oct 7, 2026 | $7.31 | $7.73 | $7.20 | $7.595 | 1M |
| Oct 6, 2026 | $7.79 | $7.84 | $7.33 | $7.45 | 1.16M |
| Oct 5, 2026 | $7.80 | $8.16 | $7.57 | $7.76 | 2.35M |
| Oct 2, 2026 | $7.58 | $7.62 | $7.36 | $7.43 | 1.04M |
| Oct 1, 2026 | $7.52 | $7.7363 | $7.30 | $7.42 | 1.71M |
| Sep 30, 2026 | $7.49 | $7.86 | $7.35 | $7.53 | 1.79M |
| Sep 29, 2026 | $7.41 | $7.64 | $7.33 | $7.45 | 2.1M |
| Sep 28, 2026 | $7.30 | $7.495 | $7.1701 | $7.47 | 1.33M |
| Sep 25, 2026 | $7.53 | $7.675 | $7.165 | $7.40 | 1.28M |
| Sep 24, 2026 | $7.45 | $7.46 | $7.12 | $7.24 | 1.52M |
Latest RGNX news
The latest Smart Investors Daily articles mentioning RGNX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

